GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (MEX:TEVA N) » Definitions » E10

Teva Pharmaceutical Industries (MEX:TEVA N) E10 : MXN-58.65 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Teva Pharmaceutical Industries E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted earnings per share data for the three months ended in Mar. 2025 was MXN3.682. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-58.65 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average E10 Growth Rate was -28.10% per year. During the past 5 years, the average E10 Growth Rate was -56.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Teva Pharmaceutical Industries was 31.40% per year. The lowest was -105.80% per year. And the median was 15.40% per year.

As of today (2025-07-06), Teva Pharmaceutical Industries's current stock price is MXN315.30. Teva Pharmaceutical Industries's E10 for the quarter that ended in Mar. 2025 was MXN-58.65. Teva Pharmaceutical Industries's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Teva Pharmaceutical Industries was 342.69. The lowest was 7.51. And the median was 29.89.


Teva Pharmaceutical Industries E10 Historical Data

The historical data trend for Teva Pharmaceutical Industries's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries E10 Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.71 -28.95 -37.59 -36.22 -55.35

Teva Pharmaceutical Industries Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.73 -45.26 -51.31 -55.35 -58.65

Competitive Comparison of Teva Pharmaceutical Industries's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Shiller PE Ratio falls into.


;
;

Teva Pharmaceutical Industries E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teva Pharmaceutical Industries's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.682/134.9266*134.9266
=3.682

Current CPI (Mar. 2025) = 134.9266.

Teva Pharmaceutical Industries Quarterly Data

per share eps CPI Adj_EPS
201506 9.885 100.684 13.247
201509 2.028 100.392 2.726
201512 9.457 99.792 12.787
201603 10.673 100.470 14.333
201606 3.699 101.688 4.908
201609 6.767 101.861 8.964
201612 -22.885 101.863 -30.313
201703 10.733 102.862 14.079
201706 -107.371 103.349 -140.177
201709 9.437 104.136 12.227
201712 -224.087 104.011 -290.693
201803 18.713 105.290 23.980
201806 -4.716 106.317 -5.985
201809 -5.050 106.507 -6.398
201812 -55.960 105.998 -71.232
201903 -1.940 107.251 -2.441
201906 -12.102 108.070 -15.110
201909 -5.725 108.329 -7.131
201912 1.886 108.420 2.347
202003 1.407 108.902 1.743
202006 3.001 108.767 3.723
202009 -87.701 109.815 -107.756
202012 2.785 109.897 3.419
202103 1.431 111.754 1.728
202106 3.782 114.631 4.452
202109 5.346 115.734 6.233
202112 -2.872 117.630 -3.294
202203 -17.123 121.301 -19.046
202206 -4.225 125.017 -4.560
202209 1.006 125.227 1.084
202212 -21.446 125.222 -23.108
202303 -3.605 127.348 -3.820
202306 -13.372 128.729 -14.016
202309 1.045 129.860 1.086
202312 6.959 129.419 7.255
202403 -1.992 131.776 -2.040
202406 -13.740 132.554 -13.986
202409 -7.679 133.029 -7.789
202412 -3.963 133.157 -4.016
202503 3.682 134.927 3.682

Add all the adjusted EPS together and divide 10 will get our e10.


Teva Pharmaceutical Industries  (MEX:TEVA N) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Teva Pharmaceutical Industries was 342.69. The lowest was 7.51. And the median was 29.89.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Teva Pharmaceutical Industries E10 Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines